Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
![](https://www.unilim.fr/cnr-herpesvirus/wp-content/uploads/sites/18/2022/06/ct.gov-nlm-nih-logo.png)